RU2000103880A - METHOD FOR SIMULATING LIVER CIRRHOSIS - Google Patents

METHOD FOR SIMULATING LIVER CIRRHOSIS

Info

Publication number
RU2000103880A
RU2000103880A RU2000103880/14A RU2000103880A RU2000103880A RU 2000103880 A RU2000103880 A RU 2000103880A RU 2000103880/14 A RU2000103880/14 A RU 2000103880/14A RU 2000103880 A RU2000103880 A RU 2000103880A RU 2000103880 A RU2000103880 A RU 2000103880A
Authority
RU
Russia
Prior art keywords
liver cirrhosis
simulating
simulating liver
solution
sovtol
Prior art date
Application number
RU2000103880/14A
Other languages
Russian (ru)
Other versions
RU2197018C2 (en
Inventor
Владимир Александрович Мышкин
Рифа Бариевна Ибатуллина
Александр Иванович Савлуков
Надежда Ивановна Симонова
Ахат Бариевич Бакиров
Original Assignee
Уфимский научно-исследовательский институт медицины труда и экологии человека
Filing date
Publication date
Application filed by Уфимский научно-исследовательский институт медицины труда и экологии человека filed Critical Уфимский научно-исследовательский институт медицины труда и экологии человека
Priority to RU2000103880/14A priority Critical patent/RU2197018C2/en
Priority claimed from RU2000103880/14A external-priority patent/RU2197018C2/en
Publication of RU2000103880A publication Critical patent/RU2000103880A/en
Application granted granted Critical
Publication of RU2197018C2 publication Critical patent/RU2197018C2/en

Links

Claims (1)

Способ моделирования цирроза печени путем введения химических веществ лабораторному животному, отличающийся тем, что в желудок вводят два раза в неделю в течение месяца 50%-ный раствор совтола-1 на оливковом масле из расчета 0,25 мл на 100 г массы тела и 10%-ный раствор этанола - вместо воды для питья.A method for modeling liver cirrhosis by introducing chemicals to a laboratory animal, characterized in that a 50% solution of Sovtol-1 in olive oil is administered twice a week for a month at a rate of 0.25 ml per 100 g of body weight and 10% ethanol solution - instead of drinking water.
RU2000103880/14A 2000-02-16 2000-02-16 Method for modeling hepatic cirrhosis RU2197018C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2000103880/14A RU2197018C2 (en) 2000-02-16 2000-02-16 Method for modeling hepatic cirrhosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2000103880/14A RU2197018C2 (en) 2000-02-16 2000-02-16 Method for modeling hepatic cirrhosis

Publications (2)

Publication Number Publication Date
RU2000103880A true RU2000103880A (en) 2001-10-27
RU2197018C2 RU2197018C2 (en) 2003-01-20

Family

ID=20230742

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2000103880/14A RU2197018C2 (en) 2000-02-16 2000-02-16 Method for modeling hepatic cirrhosis

Country Status (1)

Country Link
RU (1) RU2197018C2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2500039C1 (en) * 2012-07-31 2013-11-27 Александр Михайлович Пузиков Method for simulating primary biliary cirrhosis
RU2564758C1 (en) * 2014-03-11 2015-10-10 Федеральное государственное бюджетное учреждение "Пятигорский государственный научно-исследовательский институт курортологии Федерального медико-биологического агентства" (ФГБУ ПГНИИК ФМБА России) Method for simulating toxic hepatitis with formaline and ethanol in toxicology test
RU2669024C2 (en) * 2016-11-22 2018-10-05 Федеральное государственное бюджетное военное образовательное учреждение высшего образования Военно-медицинская академия им. С.М. Кирова Министерства обороны Российской Федерации (ВМедА) Method of modeling experimental liver cirrhosis

Similar Documents

Publication Publication Date Title
NO20062512L (en) Compositions and dosage forms for improved absorption of gabapentin and pregabalin
FR2789079B3 (en) PYRAZOLECARBOXYLIC ACID DERIVATIVE, ITS PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
EA200300081A1 (en) HYDROGEL-CONTROLLED MEDICINE FORM
TR201907729T4 (en) Pharmaceutical composition containing an anti-nucleating agent.
RU2006120946A (en) COMPOSITION OF PREGABALIN
RU2000103880A (en) METHOD FOR SIMULATING LIVER CIRRHOSIS
EA200701645A1 (en) INJECTION PREPARATIONS OF DICLOFENAK AND ITS PHARMACEUTICALLY ACCEPTANT SALTS
FR2677021B1 (en) NOVEL THIAZOLE DERIVATIVES ANTAGONISTS OF ANGIOTENSIN II RECEPTORS; THEIR PREPARATION METHODS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
FR2850573B1 (en) USE OF 3-ACETYL 11-KETO-BOSWELLIC ACID OR PLANT EXTRACT BY CONTAINING TO REDUCE EXPRESSION WRINKLES
FR2869615B1 (en) BUTANOIC ACID DERIVATIVES, PROCESSES FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AND THERAPEUTIC APPLICATIONS THEREOF
ATE214269T1 (en) LIQUID MEDICINAL SOLUTION FOR ORAL APPLICATION
RU2000103102A (en) METHOD FOR MODELING TOXIC HEPATOPATHY
RU2006112134A (en) HEPATITIS MODELING METHOD
RU2005109451A (en) METHOD FOR MODELING CHRONIC TOXIC NEPHROPATHY
RU2003115034A (en) METHOD FOR SIMULTANEOUS SIMULATION OF CHRONIC PANCREATITIS AND HEPATITIS
TH77904A (en) Pharmaceutical mixtures
FR2849601B1 (en) NOVEL SYNERGISTIC COMPOSITIONS OF BEVERAGES STIMULATING CELL METABOLISM TO IMPROVE THE EFFICACY OF PLANT EXTRACTS
RU2003108517A (en) METHOD FOR TREATING COLIBACTERIOSIS AND SALMONELLOSIS IN PIGLIES
RU2000105081A (en) USE OF "ESVICIN" FOR TREATMENT OF RHEUMATOID ARTHRITIS
RU99116495A (en) METHOD FOR MODELING Biliary PERITONITIS
RU2000126015A (en) DRUGS FOR THE TREATMENT AND PREVENTION OF DISEASES CAUSED BY THE INSUFFICIENCY OF SELENIUM IN THE BODY OF ANIMAL ANIMALS
JPS59137407A (en) Bath liquid
RU2003135006A (en) METHOD FOR TREATING BENEFIC THYROID NEOPLASMS
RU2002125603A (en) COMPOSITION WITH SEDATIVE ACTIVITY (OPTIONS)
TH136337A (en) Immunoglobulin mixtures and methods for preparing them